Generate a tailored SOP for Dr. Andrew Halayko. Improve your application with a focused, well-structured draft.
Dr. Halayko completed his PhD in Physiology at the University of Manitoba and underwent a postdoctoral fellowship in pulmonary critical care at the University of Chicago. He returned to the University of Manitoba as faculty in 1999 and has held a Tier 2 Canada Research Chair since 2006, progressing to a Tier 1 Canada Research Chair in Lung Pathobiology Treatment. Leading the Biology of Breathing Group at the Children's Hospital Research Institute of Manitoba, he focuses on asthma pathogenesis and employs multi-omics technologies and pre-clinical studies to explore disease mechanisms. Dr. Halayko has published extensively, with over 256 peer-reviewed publications and an h-index of 58 in Scopus. His research covers various aspects of lung disease, including asthma, COPD, and the impact of inhaled pollutants, contributing significantly to the field with over 16,779 citations. He has received numerous awards for his work in research and mentorship, helping to train 75 graduate students and postdoctoral fellows. Dr. Halayko also serves in leadership roles within national organizations such as the Canadian Respiratory Research Network and the American Thoracic Society, where he has held significant positions including chair of key committees.
Max Rady College of Medicine • Winnipeg, Manitoba
Professor in the Department of Physiology and Pathophysiology, leading research on lung diseases.
Streams include Education, Administration, or Clinical.